Lobe Sciences Ltd. LOBEF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.13% | -17.80% | 4.22% | 1.60% | -74.18% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -105.99% | -106.36% | -98.75% | -66.94% | 1,366.49% |
| Change in Net Operating Assets | 54.07% | 162.25% | 124.09% | 59.24% | -20.21% |
| Cash from Operations | -270.37% | -266.74% | -180.32% | -198.82% | 8.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -102.81% | -101.53% | -70.04% | -70.04% | 20.16% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 341.05% | -- | -- | -- | 2,120.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.96% | 3,115.32% | -- | -- | -- |
| Cash from Financing | -88.55% | 736.73% | 1,416.99% | 1,408.31% | 2,391.42% |
| Foreign Exchange rate Adjustments | -263.04% | 99.43% | -346.28% | -878.57% | -475.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.36% | 4,106.04% | 27,956.95% | 5,500.00% | 1,140.52% |